NCT03733249 2023-09-26Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT01744223 2022-07-12Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Active not recruiting36 enrolled
NCT03301168 2022-07-12Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Active not recruiting120 enrolled
NCT02487459 2020-10-05Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic MalignanciesBellicum PharmaceuticalsPhase 1 Withdrawn